Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue -, Pages 46126
Publisher
Springer Nature
Online
2017-05-30
DOI
10.1038/srep46126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Staurosporine allows dystrophin expression by skipping of nonsense-encoding exon
- (2016) Atsushi Nishida et al. BRAIN & DEVELOPMENT
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
- (2016) Michael Bidinosti et al. SCIENCE
- Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis
- (2015) So Masaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Deciphering targeting rules of splicing modulator compounds: case of TG003
- (2015) Maki Sakuma et al. BMC MOLECULAR BIOLOGY
- Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25–35 peptide administration in mice
- (2015) Gaëlle Naert et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation
- (2014) Brandon E. Aubol et al. BIOCHEMICAL JOURNAL
- Human CDC2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer’s Disease
- (2014) Princi Jain et al. CURRENT DRUG TARGETS
- Genome-wide Analysis Reveals SR Protein Cooperation and Competition in Regulated Splicing
- (2013) Shatakshi Pandit et al. MOLECULAR CELL
- Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree
- (2013) Matthieu Chartier et al. PeerJ
- CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential
- (2011) K Shiomi et al. GENE THERAPY
- Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor
- (2011) Kensuke Ninomiya et al. JOURNAL OF CELL BIOLOGY
- Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
- (2011) Atsushi Nishida et al. Nature Communications
- RNA-targeted splice-correction therapy for neuromuscular disease
- (2010) M. J. A. Wood et al. BRAIN
- Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
- (2010) Alexander Karlas et al. NATURE
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
- (2009) Annemieke Aartsma-Rus et al. LANCET NEUROLOGY
- Cooperative-Binding and Splicing-Repressive Properties of hnRNP A1
- (2009) H. L. Okunola et al. MOLECULAR AND CELLULAR BIOLOGY
- RNA-targeting approaches for neuromuscular diseases
- (2009) Florence Le Roy et al. TRENDS IN MOLECULAR MEDICINE
- The SR protein family
- (2009) Peter J Shepard et al. GENOME BIOLOGY
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A
- (2008) Jun-ichiro Yomoda et al. GENES TO CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search